EGFR and colorectal cancer: In 2017, a panel of experts from the American Society of Clinical Pathology, the College of American Pathologists, the Association for Molecular Pathology, and the American Society of Clinical Oncology established consensus guidelines aimed at standardizing the identification of key molecular biomarkers in colorectal cancer tissues to guide epidermal growth factor receptor (EGFR)-targeted therapies and conventional chemotherapy protocols [122].